ATARA BIOTHERAPEUTICS INC's ticker is ATRA and the CUSIP is 046513107. A total of 110 filers reported holding ATARA BIOTHERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.05 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $9,716,000 | -41.4% | 616,488 | -33.5% | 1.26% | -35.3% |
| Q3 2021 | $16,586,000 | -19.5% | 926,588 | -30.1% | 1.94% | +0.9% |
| Q2 2021 | $20,607,000 | -14.1% | 1,325,188 | -20.6% | 1.92% | -14.1% |
| Q1 2021 | $23,976,000 | -19.9% | 1,669,645 | +9.5% | 2.24% | -1.9% |
| Q4 2020 | $29,931,000 | +46.0% | 1,524,760 | -3.6% | 2.28% | +39.2% |
| Q3 2020 | $20,507,000 | -21.2% | 1,582,360 | -11.4% | 1.64% | -31.9% |
| Q2 2020 | $26,019,000 | +36.1% | 1,785,784 | -20.5% | 2.41% | +8.9% |
| Q1 2020 | $19,117,000 | -60.4% | 2,246,401 | -23.4% | 2.21% | -36.5% |
| Q4 2019 | $48,304,000 | +28.6% | 2,932,865 | +10.2% | 3.48% | +12.2% |
| Q3 2019 | $37,574,000 | +8.7% | 2,661,020 | +54.7% | 3.10% | +14.4% |
| Q2 2019 | $34,582,000 | -50.4% | 1,719,642 | -1.9% | 2.71% | -50.8% |
| Q1 2019 | $69,669,000 | -9.1% | 1,752,690 | -20.6% | 5.51% | -13.7% |
| Q4 2018 | $76,668,000 | -24.6% | 2,206,917 | -10.3% | 6.39% | +8.6% |
| Q3 2018 | $101,690,000 | +12.5% | 2,459,253 | 0.0% | 5.88% | +20.2% |
| Q2 2018 | $90,378,000 | -8.7% | 2,459,253 | -3.1% | 4.90% | -18.5% |
| Q1 2018 | $99,030,000 | +110.5% | 2,539,223 | -2.3% | 6.01% | +93.5% |
| Q4 2017 | $47,035,000 | +72.0% | 2,598,599 | +57.3% | 3.10% | +89.5% |
| Q3 2017 | $27,349,000 | +28.2% | 1,652,513 | +8.4% | 1.64% | +34.5% |
| Q2 2017 | $21,339,000 | -26.3% | 1,524,191 | +8.2% | 1.22% | -26.3% |
| Q1 2017 | $28,953,000 | +155.4% | 1,408,905 | +76.5% | 1.65% | +109.6% |
| Q4 2016 | $11,336,000 | -46.8% | 798,321 | -19.9% | 0.79% | -45.1% |
| Q3 2016 | $21,306,000 | -6.8% | 996,076 | -2.0% | 1.44% | -2.8% |
| Q2 2016 | $22,870,000 | +62.5% | 1,015,976 | +37.4% | 1.48% | +51.8% |
| Q1 2016 | $14,072,000 | -24.6% | 739,444 | +4.6% | 0.97% | +57.7% |
| Q4 2015 | $18,668,000 | -19.2% | 706,848 | -3.8% | 0.62% | -60.8% |
| Q3 2015 | $23,090,000 | -12.7% | 734,418 | +46.5% | 1.58% | +88.4% |
| Q2 2015 | $26,448,000 | +34.0% | 501,297 | +5.6% | 0.84% | -36.6% |
| Q1 2015 | $19,739,000 | +203.1% | 474,835 | +95.0% | 1.32% | +221.7% |
| Q4 2014 | $6,512,000 | – | 243,450 | – | 0.41% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Antipodean Advisors LLC | 1,000,000 | $1,480,000 | 7.58% |
| Redmile Group, LLC | 6,280,813 | $9,295,603 | 0.44% |
| Arctis Global LLC | 397,046 | $587,628 | 0.32% |
| Baupost Group | 9,773,616 | $14,465 | 0.28% |
| JOSH ARNOLD INVESTMENT CONSULTANT, LLC | 230,000 | $413,400 | 0.24% |
| MAVERICK CAPITAL LTD | 6,290,713 | $9,310,255 | 0.21% |
| 683 Capital Management, LLC | 1,200,000 | $1,776,000 | 0.14% |
| STALEY CAPITAL ADVISERS INC | 1,000,000 | $1,480,000 | 0.08% |
| WASATCH ADVISORS LP | 8,399,229 | $12,430,859 | 0.08% |
| PACIFIC HEIGHTS ASSET MANAGEMENT LLC | 525,000 | $777,000 | 0.07% |